⌕
10x Genomics · TXG · Nasdaq
Tenet 51 · Mixed
Compare
$54.99−5.50%At closeTenet 51 · Mixed
$54.99−3.20 (−5.50%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

10x Genomics (TXG) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 397 filers, Jun 30, 2026
# 13F FUNDS
397
13F VALUE
$4.9B
129.1M shares
Not reported in the company's filings for this period.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Sep 22, 2026SULIMAN SHEHNAAZdirectorDisposed · Open-market sale292$78.20↗
Sep 22, 2026SULIMAN SHEHNAAZdirectorDisposed · Open-market sale614$79.51↗
Sep 22, 2026SULIMAN SHEHNAAZdirectorDisposed · Open-market sale1,325$80.82↗
Sep 22, 2026SULIMAN SHEHNAAZdirectorDisposed · Open-market sale2,270$81.67↗
Sep 22, 2026SULIMAN SHEHNAAZdirectorDisposed · Open-market sale1,222$82.28↗
Sep 22, 2026Saxonov SergeChief Executive OfficerDisposed · Open-market sale1,000$78.23↗
Sep 22, 2026Saxonov SergeChief Executive OfficerDisposed · Open-market sale2,000$79.62↗
Sep 22, 2026Saxonov SergeChief Executive OfficerDisposed · Open-market sale9,300$80.90↗
Sep 22, 2026Saxonov SergeChief Executive OfficerDisposed · Open-market sale9,900$81.83↗
Sep 22, 2026Saxonov SergeChief Executive OfficerDisposed · Open-market sale2,800$82.37↗
Sep 9, 2026Taich AdamChief Financial OfficerDisposed · Open-market sale1,206$63.68↗
Sep 9, 2026Taich AdamChief Financial OfficerDisposed · Open-market sale31,428$64.31↗
Sep 9, 2026Taich AdamChief Financial OfficerDisposed · Open-market sale13,754$65.26↗
Sep 3, 2026STUELPNAGEL JOHN RdirectorDisposed · Open-market sale7,012$60.66↗
Sep 3, 2026STUELPNAGEL JOHN RdirectorDisposed · Open-market sale6,814$62.11↗
Sep 3, 2026STUELPNAGEL JOHN RdirectorDisposed · Open-market sale6,174$62.61↗
Sep 1, 2026Saxonov SergeChief Executive OfficerDisposed · Gift100—↗
Aug 26, 2026Saxonov SergeChief Executive OfficerDisposed · Open-market sale3,500$63.02↗
Aug 26, 2026Saxonov SergeChief Executive OfficerDisposed · Open-market sale6,494$63.98↗
Aug 26, 2026Saxonov SergeChief Executive OfficerDisposed · Open-market sale492$64.75↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold 10x Genomics?

10x Genomics was held by 397 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.